Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arbor Vita Corp.

www.arborvita.com

Latest From Arbor Vita Corp.

HHS Pressured By Lawmakers To Release Pandemic-Flu Plan

Two House Committee leaders are asking HHS Secretary Tom Price about the current status of an overdue pandemic influenza preparedness plan, including diagnostic advancements, that was promised last August. The lawmakers say they are worried about a US return of the H7N9 avian influenza virus, which re-emerged in China earlier this year.

In Vitro Diagnostics Infectious Diseases

Deals Shaping The Medical Industry, October 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.

BioPharmaceutical Medical Device

Medical Device Deals Update, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.

Medical Device Deals

FDA Grants Third Emergency-Use Authorization For H7N9 Flu Test

The April 25 emergency authorization covers the use of Arbor Vita Corp.’s rapid H7N9 assay in government laboratories on U.S. citizens who are suspected of exposure to the variant of avian flu in China.

Medical Device Regulation
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Arbor Vita Corp.
  • Senior Management
  • Peter S Lu, MD, Pres. & CEO
    Johannes G Schweizer, PhD, VP, R&D
    Olga Petrauskene, PhD, Dir., Prod. Dev., Mktg., & Bus. Dev.
  • Contact Info
  • Arbor Vita Corp.
    Phone: (408) 585-3900
    48371 Fremont Blvd.
    Ste. 101
    Fremont, CA 94538
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register